608
Participants
Start Date
September 5, 2017
Primary Completion Date
March 15, 2021
Study Completion Date
April 20, 2023
Cemiplimab
Intravenous (IV) administration every 3 weeks (Q3W)
Investigator Choice (IC) Chemotherapy
"IC chemotherapy options include:~1. Antifolate: Pemetrexed~2. Topoisomerase 1 inhibitor: Topotecan or Irinotecan~3. Nucleoside analogue: Gemcitabine~4. Vinca alkaloid: Vinorelbine~The only chemotherapy treatments allowed in the control arm are any of the 5 drugs that are listed as IC options above."
Koo-Foundation Sun Yat-Sen Cancer Center, Taipei
Taipei Veterans General Hospital, Taipei
Institut Bordet, Brussels
Cliniques universitaires Saint-Luc, Brussels
St. George Hospital, Kogarah
Northern NSW Health District, The Tweed Hospital, Tweed Heads
UZLeuven Gynaelologic Oncology, Leuven
CHC Saint Joseph, Liège
CHU Liège, Liège
Royal Brisbane & Women's Hospital, Herston
CHU UCL Namur site Sainte Elisabeth, Namur
St. John of God Subiaco Hospital, Subiaco
Sir Charles Gairdner Hospital, Nedlands
OLV ziekenhuis Aalst, Medische oncologie- Radiotherapie, Aalst
Laura and Issac Perlmutter Cancer Center at NYU Langone, New York
National Cancer Center, Goyang-si
MacKay Memorial Hospital, Taipei
Northwell Health, Lake Success
New York Presbyterian Queens, Flushing
General Hospital of Athens Alexandra, Athens
Hospital Reina Sofia, Córdoba
Instituto Catalan de Oncologia de Gerona, Girona
Thomas Jefferson University Hospital, Philadelphia
Istituto Europeo di Oncologia, Milan
Asst Lecco, Lecco
General Hospital of Patras, Pátrai
Hospital Ramon y Cajal, Madrid
Hospital Universitario HM Sanchinarro CIOCC, Madrid
First Health of the Carolinas Outpatient Cancer Center, Pinehurst
Hospital Virgen de la Victoria, Málaga
Azienda Ospedaliero Universitaria di Bologna, Bologna
Taichung Veterans General Hospital, Taichung
Keimyung University Dongsan Medical Center, Daegu
AUSL, IRCCS di Reggio Emilia, Reggio Emilia
University Hospital of Ioannina, Ioannina
Fundacion Instituto Valenciano de Oncologia, Valencia
Hospital Universitario La Fe, Valencia
Irst Irccs, Meldola
Hospital Clinico Universitario Lozano Blesa, Zaragoza
Euromedica General Clinic, B'Oncology Clinic, Thessaloniki
Cancer Research for the Ozarks, Springfield
Ochsner Clinic Foundation, New Orleans
U.O Oncologia Medica P.O Vito Fazzi, Lecce
Texas Oncology, P.A., Austin
Arizona Oncology Associates, Phoenix
Arizona Oncology Associates, Tucson
University of California Irvine, Orange
Regional Budgetary Institution of Healthcare Ivanovo Regional Oncology Dispensary, Ivanovo
"State Budgetary Healthcare Institution Leningrad Regional Oncological Dispensary (SBHI LROD)", Vsevolozhsk
"Saint- Petersburg State Budgetary institution of Healthcare City Clinical Oncological Dispensary", Saint Petersburg
A. Tsyb Medical Radiological Research Center, Obninsk
State Budgetary Institution of Healthcare, Clinical Oncology Dispensary #1 of Ministry of Health of Krasnodar Region, Krasnodar
"State Budgetary Healthcare Institution Oncology Dispensary of Ministry of Healthcare of the Kabardino-Balkarian Republic", Nal'chik
State Autonomous Healthcare Institution ,Republican Clinical Oncological Dispensary of the Ministry of Healthcare of the Tatarstan Republic, Kazan'
"State Budgetary Institution of Healthcare Orenburg Regional Clinical Oncology Dispensary", Orenburg
Budgetary Institution of Healthcare of Omsk region Clinical Oncology Dispensary, Omsk
Peter MacCallum Cancer Centre, Melbourne
Liga Norte Riograndense Contra o Câncer, Natal
Hosptial Sao Lucas da PUC de Porto Alegre, Porto Alegre
Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre
Centro de Novos Tratamentos Itajai, Itajaí
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos
Instituto de Pesquisas Clinicas para Estudos Multicentricos - IPCEM, Caxias do Sul
Instituto Nacional de Cancer - INCA, Rio de Janeiro
Instituto COI de Pesquisa, Rio de Janeiro
Tom Baker Cancer Center, Calgary
British Columbia Cancer Agency, Vancouver
London Health Sciences Centre, London
Princess Margaret Cancer Centre, Toronto
Hospital Maisonneuve-Rosemont, Montreal
Hopital Notre-Dame du Centre Hospitalier de l'Universite de Montreal, Montreal
Jewish General Hospital, Montreal
Fondazione Policlinico Agostino Gemelli IRCCS di Roma, Roma
Regina Elena National Cancer Institute, Rome
Shikoku Cancer Center, Matsuyama
Ehime University Hospital, Tōon
Fukui University Hospital, Yoshida-gun
Kurume University Hospital, Kurume
Hokkaido University Hospital, Sapporo
St. Marianna University School of Medicine Hospital, Kawasaki
University of the Ryukyus Hospital, Nakagami-gun
Saitama Medical University, Saitama
National Cancer Center Hospital, Chuo-ku
The Cancer Institute Hospital of JFCR, Koto-Ku
Kyorin University Hospital, Mitaka
Saitama Cancer Center, Saitama
National Kyushu Cancer Center, Fukuoka
Kagoshima City Hospital, Kagoshima
Bialostockie Centrum Onkologii, Bialystok
Szpitale Pomorskie, Gdynia
Center and Institute of Oncology Gliwice, Gliwice
Centrum Onkologii Ziemi Lubelskiej im sw. Jana z Dukli, Lublin
Greater Poland Cancer Center, Poznan
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Gangnam Severance Hospital, Seoul
Korea University Guro Hospital, Seoul
Hospital Universitario Son Espases, Palma de Mallorca
Vall d´Hebron University Hospital, Barcelona
Velindre Cancer Centre, Cardiff
NHS Greater Glasgow and Clyde Beatson, West of Scotland Cancer care, Glasgow
University College Hospital, London
Royal Marsden NHS Foundation Trust, Chelsea, London
Nottingham University Hospitals NHS Trust, Nottingham
Royal Marsden NHS Foundation Trust, Sutton, Sutton
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY